Дмитренко, І. В. 2018. “Prognostic Value of Early Reduction of BCR/ABL1 Gene Expression in Criteria of Deep Molecular Response on Imatynib Therapy in Patients With Chronic Myeloid Leukemia”. Problems of Environmental Biotechnology, no. 1 (June). https://doi.org/10.18372/2306-6407.1.12851.